We also performed meta-analysis for each cancer type to summarize results from different cohorts, and found that NFE2L2 MU did not have a significant association with OS (HR: 0.94, 95% CI 0.70 − 1.26; Additional file 1: Fig. S5A). Here, NFE2L2 is linked to cancer.